Biotubes for tissue engineering

By injecting the extracellular matrix of living cells into vascular grafts and forming microchannels, the problems of immunogenicity and difficult materials in existing vascular transplantation technologies are solved, and biological flow is restored in the body and cardiovascularization is reduced. Effects of disease symptoms.

CN113038908BActive Publication Date: 2024-11-12BIOSAPIEN INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN201980074842.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2018-09-14
Filing Date
2019-09-13
Publication Date
2024-11-12
Estimated Expiration
2039-09-13

AI Technical Summary

Technical Problem

The existing vascular transplantation technology has immunogenicity problems and difficult to obtain materials, making it difficult to effectively treat cardiovascular diseases and other diseases.

Method used

Develop a vascular graft containing hollow cylinders, the inner and outer walls consist of polymers, injected into the extracellular matrix of living cells, and form multiple microchannels in the void space, prepared by bioprinting technology for in vivo transplantation to increase the flow of biological fluid.

Benefits of technology

This vascular graft can restore the normal flow of biological fluids in the body, alleviate disease symptoms, such as cardiovascular disease, and reduce the risk of immune response through the combination of biocompatible polymers and living cells, and improve the therapeutic effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN113038908B_ABST
    Figure CN113038908B_ABST
Patent Text Reader

Abstract

Described herein are bioengineered constructs and methods for their production. The constructs and methods disclosed herein can be applied, for example, to the generation of vascular grafts to treat cardiovascular disease.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] Cross-references

[0002] This application claims the benefit of U.S. Provisional Application No. 62 / 731,564, filed September 14, 2018, which is incorporated herein by reference in its entirety. Background Art

[0003] Cardiovascular disease is the leading cause of death worldwide. In some cases, cardiovascular disease can be treated with vascular grafts, which improve blood flow to organs supplied by diseased or damaged blood vessels. Vascular grafts can rely on the use of allogeneic graft material for transplantation, which may cause immunogenicity. Therefore, alternative methods of preparing vascular grafts may be beneficial to patients with cardiovascular disease.

[0004] Incorporation by reference

[0005] All publications, patents, and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication, patent, or patent application was specifically and individually indicated to be incorporated by reference. Summary of the invention

[0006] In some embodiments, the present disclosure provides a vascular graft comprising a hollow cylinder, wherein the hollow cylinder comprises a first opening and a second opening, and wherein the hollow cylinder comprises: (a) a main channel, wherein the main channel comprises an inner wall and an outer wall with a void space between the inner wall and the outer wall, wherein the inner wall and the outer wall are composed of a polymer; and (b) a viable cell-infused extracellular matrix disposed within the void space, and wherein the void space comprises a microstructure comprising a plurality of microchannels.

[0007] In some embodiments, the present disclosure provides a vascular graft comprising a hollow cylinder, wherein the hollow cylinder comprises a first opening and a second opening, and wherein the hollow cylinder comprises: (a) a main channel, wherein the main channel comprises an inner wall and an outer wall with a void space between the inner wall and the outer wall, wherein the inner wall and the outer wall are composed of a polymer; and (b) an extracellular matrix infused with living cells disposed within the void space, and wherein the void space comprises a microstructure comprising a plurality of microchannels, wherein the vascular graft is immersed in a medium that promotes growth of cells in the extracellular matrix infused with living cells.

[0008] In some embodiments, the present disclosure provides a method of increasing the flow of a biological fluid in a blood vessel of a subject in need thereof, the method comprising implanting a vascular graft in the subject, wherein the vascular graft comprises a hollow cylinder, and wherein the hollow cylinder comprises: (a) a main channel, wherein the main channel comprises an inner wall and an outer wall with a void space between the inner wall and the outer wall, wherein the inner wall and the outer wall are composed of a polymer; and (b) an extracellular matrix infused with living cells disposed in the void space, and wherein the void space comprises a microstructure comprising a plurality of microchannels, wherein implanting the vascular graft in the subject increases the flow of a biological fluid in a blood vessel of the subject.

[0009] In some embodiments, the present disclosure provides a method of printing a vascular graft, the method comprising: (a) depositing a polymer on a substrate to form an inner wall; (b) depositing an extracellular matrix infused with living cells on the inner wall; (c) depositing a polymer on the extracellular matrix infused with living cells to form an outer wall, wherein the deposition of steps (a), (b), and (c) forms a hollow cylinder, wherein the hollow cylinder comprises a first opening and a second opening, and wherein the hollow cylinder comprises a main channel, wherein the main channel comprises an inner wall and an outer wall; and wherein the vascular graft is printed to provide a microstructure comprising a plurality of microchannels in the void space. BRIEF DESCRIPTION OF THE DRAWINGS

[0010] Figure 1 A cross-sectional view of the main channel of a vascular construct is shown. The inset on the right is an enlarged view showing the structure of the channel wall.

[0011] Figure 2 A cross-sectional view of a vascular construct containing a bifurcation in the main channel is shown.

[0012] Figure 3 Shown is a cross-sectional view of the side of a vascular construct containing a bifurcation in a main channel and multiple branches emanating from the main channel. PCL = Polycaprolactone.

[0013] Figure 4 A branching structure is shown, wherein the walls of the branches comprise a mixture of polymeric material and cell-infused extracellular matrix material.

[0014] Figure 5 A branching structure is shown, wherein the walls of the branches comprise a polymer material surrounding a central core of extracellular matrix material. PCL = polycaprolactone.

[0015] Figure 6 The honeycomb microstructure of cylindrical tubes forming the walls of the main channel is shown.

[0016] Figure 7A cylindrical tube with triangular substructures forming the microstructure is shown.

[0017] Figure 8 A cross section of a cylindrical tube forming the wall of the main channel is shown. DETAILED DESCRIPTION

[0018] Vascular grafts and methods for making the same are described herein. Vascular grafts of the present disclosure can alleviate conditions by restoring the normal flow of biological fluids to tissues. For example, vascular grafts disclosed herein can be used to treat diseases / disorders, such as cardiovascular disease, cerebrovascular disease, lymphatic system disease, eye disease, edema, lung disease, and urinary tract disease. Non-limiting examples of tubes that can be integrated or connected to vascular grafts of the present disclosure include blood vessels, lymphatic vessels, Schlemm's canal, ureters, urethra, lacrimal canaliculi, and airway passages. In some embodiments, vascular grafts disclosed herein facilitate the transport of fluids. Non-limiting examples of fluids that can be transported by vascular grafts of the present disclosure include blood, lymph, cerebrospinal fluid, urine, semen, air, tears, bile, aqueous humor, saliva, and breast milk.

[0019] Cardiovascular disease

[0020] The vascular grafts disclosed herein can treat, for example, cardiovascular disease. Cardiovascular disease includes a wide range of diseases that affect the heart or blood vessels. Subtypes of cardiovascular disease that affect blood vessels are called vascular disease. The presence of vascular disease can lead to reduced blood flow to target tissues, which in turn can lead to tissue damage. Non-limiting examples of vascular diseases that can be treated using the vascular grafts disclosed herein include coronary artery disease, cerebrovascular disease, renal artery stenosis, erythromelalgia, Buerger's disease, and atherosclerosis.

[0021] The underlying mechanisms and symptoms of vascular disease may vary depending on the type of disease. Coronary artery disease can be caused by plaque buildup in the heart's arteries, which reduces blood flow to the heart muscle. There are several types of coronary artery disease, including, for example, stable angina, unstable angina, myocardial infarction, and sudden cardiac death. Symptoms of coronary artery disease can include pain in the chest, shoulders, arms, back, neck, or jaw, and shortness of breath.

[0022] Cerebrovascular disease can be caused by abnormal blood flow in the blood vessels that supply the brain. Abnormal blood flow can be caused by, for example, arteriovenous malformations (abnormal tangles of blood vessels), ruptured blood vessels, protein accumulation in blood vessels, ruptured aneurysms, atherosclerosis, thrombosis, or vascular stenosis. Insufficient blood flow to brain cells can lead to stroke, resulting in cell death. Symptoms of cerebrovascular disease can include, for example, weakness on one side of the face or body, difficulty balancing, decreased cognitive ability, changes in speech, vomiting, stiff neck, migraines, and seizures.

[0023] Renal artery stenosis can be caused by narrowing of the renal arteries and can be caused by atherosclerosis or fibromuscular dysplasia, a non-atherosclerotic, non-inflammatory condition that causes abnormal growths within the artery walls. Renal stenosis can lead to decreased blood flow to the kidneys. Decreased blood flow to the kidneys can lead to structural changes in the kidneys, abnormal glomerular filtration rate, and kidney failure.

[0024] Erythromelalgia is a condition in which blood vessels, usually in the extremities, become blocked in fits. The blocked blood vessels then become engorged and inflamed. Symptoms of erythromelalgia include painful burning sensations in the extremities, swelling,

[0025] Buerger's disease involves progressive inflammation and thrombosis of the blood vessels of the hands and feet. Buerger's disease can cause pain in the limbs and lead to ulcers and gangrene, which can lead to the need for amputation.

[0026] Atherosclerosis can be caused by high levels of low-density lipoprotein (LDL) in the blood. High LDL levels can lead to plaque buildup within the arteries, which can cause blockages in blood flow. Depending on the blood vessels affected, atherosclerosis can lead to a number of other conditions, including cardiovascular disease and cerebrovascular disease.

[0027] Treatment of vascular disease

[0028] Vascular diseases can be treated using the vascular grafts described herein. Vascular grafts can redirect blood flow from one area to another by reconnecting blood vessels. For example, a vascular graft can be used to bypass diseased or blocked blood vessels from one area with relatively normal blood flow to another area with relatively normal blood flow. Bypassing blocked or diseased blood vessels can restore blood flow to tissues and can be used to treat vascular diseases. In some embodiments, the vascular grafts disclosed herein can be used to bypass stenotic areas in blood vessels.

[0029] Vascular grafts can come from the subject's own blood vessels (autologous transplants) or from donor blood vessels (allogeneic transplants). The use of autologous transplants involves the creation of a second surgical site in the subject, while allogeneic transplants can pose immunogenicity concerns and are not always readily available. These issues with autologous and allogeneic transplants can be overcome with synthetic vascular grafts that contain biocompatible polymers.

[0030] In some embodiments, the vascular grafts disclosed herein are used to treat vascular diseases. For example, the vascular grafts of the present disclosure can bypass blocked or damaged blood vessels by connecting two areas with relatively normal blood flow. Non-limiting examples of blood vessels that can be connected by the vascular grafts of the present disclosure include, for example, arteries, veins, arterioles, venules, elastic arteries, distributed arteries, capillaries, venules, sinusoids, and any combination thereof. In some embodiments, the vascular grafts of the present disclosure connect two lymphatic vessels. The vascular grafts of the present disclosure can restore, increase, or control the flow of fluids such as blood or lymph to, for example, the heart, brain, lungs, kidneys, spleen, liver, pancreas, gallbladder, stomach, intestines, arms, legs, feet, hands, fingers, toes, skin, penis, vagina, ovaries, breasts, muscles, eyes, nose, and esophagus.

[0031] Vascular grafts

[0032] In some embodiments, the vascular graft disclosed herein comprises a hollow cylinder having a first opening and a second opening at both ends of the hollow body. The hollow cylinder may contain one or more channels, including a main channel. The main channel may include an inner cavity formed by a channel wall. The channel wall may include an inner wall and an outer wall to form a void space within the wall of the main channel. In some embodiments, the main channel is bifurcated into two or more secondary channels. In some embodiments, the main channel is divided into 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or more secondary channels. In some embodiments, the secondary channel may include a channel wall having an inner wall and an outer wall forming a void space. In some embodiments, the channel wall includes a microchannel. In some cases, the microchannel can provide an additional flow path for fluid through the vascular graft.

[0033] In some embodiments, the main channel, the secondary channel and its components include polymeric materials. Non-limiting examples of polymeric materials include polyesters, poly (alpha-hydroxy acids), polylactones, polyorthoesters, polycarbonates, polyanhydrides, polyphosphazenes, polycaprolactones (PCL), polylactic acid (PLA), poly-L-lactide-glycolic acid (PLGA), polyethylene glycol diacrylate (PEGDA), polyethylene glycol (PEG), poly (hydroxyethyl methacrylate) (PHEMA), polyvinyl alcohol (PVA), polyvinyl pyrrolidone (PVP), carboxymethyl cellulose (CMC), polyimide (PI), polyacrylate (PAA), polyurethane (PU), PEG-lactide and PEG-glycolide.

[0034] The polymeric materials disclosed herein can be biocompatible and / or biodegradable. Biocompatible materials can remain in the body without causing harm. Biodegradable materials can decompose in the body without causing harm. In addition, biodegradable materials can form harmless degradation products. In some embodiments, the vascular grafts disclosed herein comprise biocompatible polymeric materials. In some embodiments, the vascular grafts disclosed herein comprise biodegradable polymeric materials.

[0035] The void space of the primary or secondary channels can be filled with, for example, an extracellular matrix (ECM) material. Non-limiting examples of ECM materials include Basement membrane substrate, carrageenan, carbomer, chitosan, sodium alginate, collagen type I, collagen type III, collagen type IV, collagen type V, collagen type VI, collagen type VII, collagen type VIII, collagen type IX, collagen type X, collagen type XI, collagen type XII, collagen type XIII, collagen type XIV, collagen type XV, collagen type XVI, collagen type XVII, collagen type XVIII, collagen type XIX In some embodiments, the ECM material is seeded with cells.

[0036] In some embodiments, the void space of the channel wall comprises a microstructure containing a plurality of cylindrical tubes. The cylindrical tubes forming the microstructure can be arranged into a pattern to form the microstructure. For example, the cylindrical tubes can be arranged into a circular, triangular, rectangular, pentagonal, hexagonal, heptagonal or octagonal pattern. In some embodiments, the substructure can be present inside the cylindrical tube. The substructure can be, for example, a triangle, rectangle, pentagon, hexagon, heptagon or octagon. In some embodiments, the substructure comprises an ECM material, such as any ECM material disclosed herein. Living cells can be injected into the ECM material. In some embodiments, the wall of the cylindrical tube forming the microstructure can comprise a microchannel.

[0037] The vascular graft disclosed herein may include living cells. The presence of living cells in the vascular graft can promote the graft to combine with surrounding tissues after implantation. In some embodiments, the substructure inside the cylindrical tube of the microstructure includes cells. In some embodiments, the void space of the channel wall is filled with 1 layer, 2 layers, 3 layers, 4 layers, 5 layers, 6 layers, 7 layers, 8 layers, 9 layers, 10 layers, 11 layers, 12 layers, 13 layers, 14 layers, 15 layers or more layers of cells. In some embodiments, the inner wall or outer wall of the channel wall is filled with 1 layer, 2 layers, 3 layers, 4 layers, 5 layers, 6 layers, 7 layers, 8 layers, 9 layers, 10 layers, 11 layers, 12 layers, 13 layers, 14 layers, 15 layers or more layers of cells. For example, the void space or channel wall may include a fibroblast layer, a smooth muscle cell layer and an endothelial cell layer.

[0038] In some embodiments, the vascular graft or its precursor comprises a spheroid of cells attached to the distal end of a branch, which is connected to the main channel of the vascular graft or its precursor at the proximal end of the branch. The branch may comprise a cylindrical wall that defines a hollow core of the branch. In some embodiments, the cylindrical wall of the branch comprises a polymer material, such as any polymer material disclosed herein. In some embodiments, the cylindrical wall of the branch surrounds a central core of an extracellular matrix material such as any ECM material disclosed herein. In addition, the central core of the branch may comprise a mixture of an ECM material and a polymer material such as any polymer material disclosed herein.

[0039] Non-limiting examples of cells that may be included in a graft of the present disclosure include chondroblasts, chondrocytes, chondroprogenitor cells, chondrogenic precursors, keratinocytes, hair root cells, hair stem cells, hair matrix cells, exocrine secretory epithelial cells, hormone secreting cells, epithelial cells, neural or sensory cells, photoreceptor cells, muscle cells, extracellular matrix cells, blood cells, cardiovascular cells, endothelial cells, vascular smooth muscle cells, kidney cells, pancreatic cells, immune cells, stem cells, germ cells, mesenchymal cells, stellate cells, hepatocytes, gastrointestinal cells, lung cells, tracheal cells, vascular cells, skeletal muscle cells, cardiomyocytes, skin cells, smooth muscle cells, connective tissue cells, corneal cells, urogenital cells, , mammary cells, germ cells, endothelial cells, epithelial cells, fibroblasts, Schwann cells, adipocytes, osteocytes, bone marrow cells, chondrocytes, pericytes, mesothelial cells, endocrine tissue derived cells, stromal cells, progenitor cells, lymphocytes, endoderm derived cells, ectoderm derived cells, mesoderm derived cells, pericytes, chondroblasts, mesenchymal stem cells, connective tissue fibroblasts, tendon fibroblasts, bone marrow reticular tissue fibroblasts, non-epithelial fibroblasts, pericytes, osteoprogenitor cells, osteoblasts, osteoclasts, articular chondrocytes, stem cells, progenitor cells, totipotent cells, pluripotent stem cells, multipotent stem cells, induced pluripotent stem cells and cells derived from any of the above cells. The cell can be from, for example, mouse, rat, pig, sheep, goat, monkey or human.

[0040] A certain percentage of the cells of the vascular graft disclosed herein can be viable. In some embodiments, about 50%, about 60%, about 70%, about 80%, about 90% or about 100% of the cells of the vascular graft are viable. In some embodiments, about 50%-about 60%, about 50%-about 70%, about 50%-about 80%, about 50%-90%, about 50%-about 100%, about 60%-about 70%, about 60%-about 80%, about 60%-about 90%, about 60%-about 100%, about 70%-about 80%, about 70%-about 90%, about 70%-about 100%, about 80%-about 90%, about 80%-about 100% or about 90%-about 100% of the cells of the vascular graft disclosed herein are viable. In some embodiments, at least about 50%, at least about 60%, at least about 70%, at least about 80%, or at least about 90% of the cells of a vascular graft disclosed herein are viable.

[0041] In some embodiments, the vascular grafts disclosed herein include lithium phenyl 2-4-6 trimethylbenzoylphosphite (LAP). LAP can protect cells from free radical damage, harmful wavelengths, and photoinitiators that can be used to crosslink ECM materials. In some embodiments, LAP is present in ECM materials (e.g., ) or in the medium increases the polymerization rate, provides cell coating at reduced initiator concentrations, and thus improves cell viability.

[0042] Dimensions

[0043] The diameter of the lumen of the main channel (luminal diameter) affects the flow of fluid through the vascular graft. In some embodiments, the vascular grafts disclosed herein have a main channel with a lumen diameter of about 1 cm to about 10 cm. In some embodiments, the vascular grafts disclosed herein have a lumen diameter of about 1 cm to about 1.5 cm, about 1 cm to about 2 cm, about 1 cm to about 2.5 cm, about 1 cm to about 3 cm, about 1 cm to about 3.5 cm, about 1 cm to about 4 cm, about 1 cm to about 4.5 cm, about 1 cm to about 5 cm, about 1 cm to about 10 cm, about 1.5 cm to about 2 cm, about 1.5 cm to about 2.5 cm, about 1.5 cm to about 3 cm, about 1.5 cm to about 3.5 cm, about 1.5 cm to about 4 cm, about 1.5 cm to about 5 cm, about 1.5 cm to about 10 cm, about 2 cm to about 2.5 cm, about 2 cm to about 3 cm, about 2 cm to about 3.5 cm, about 2 cm to about 4 cm, about 2 cm to about 4.5 cm, about 1 cm to about 5 cm, about 1.5 cm to about 10 cm. The main channel may be about 5 cm, about 2 cm to about 5 cm, about 2 cm to about 10 cm, about 2.5 cm to about 3 cm, about 2.5 cm to about 3.5 cm, about 2.5 cm to about 4 cm, about 2.5 cm to about 4.5 cm, about 2.5 cm to about 5 cm, about 2.5 cm to about 10 cm, about 3 cm to about 3.5 cm, about 3 cm to about 4 cm, about 3 cm to about 4.5 cm, about 3 cm to about 5 cm, about 3 cm to about 10 cm, about 3.5 cm to about 4 cm, about 3.5 cm to about 4.5 cm, about 3.5 cm to about 5 cm, about 3.5 cm to about 10 cm, about 4 cm to about 4.5 cm, about 4 cm to about 5 cm, about 4 cm to about 10 cm, or about 5 cm to about 10 cm. In some embodiments, the vascular grafts disclosed herein have a main channel with a lumen diameter of about 1 cm, about 1.5 cm, about 2 cm, about 2.5 cm, about 3 cm, about 3.5 cm, about 4 cm, about 4.5 cm, about 5 cm, or about 10 cm. In some embodiments, the vascular grafts disclosed herein have a main channel with a lumen diameter of at least about 1 cm, at least about 1.5 cm, at least about 2 cm, at least about 2.5 cm, at least about 3 cm, at least about 3.5 cm, at least about 4 cm, at least about 4.5 cm, or at least about 5 cm. In some embodiments, the vascular grafts disclosed herein have a main channel with a lumen diameter of at most about 1.5 cm, at most about 2 cm, at most about 2.5 cm, at most about 3 cm, at most about 3.5 cm, at most about 4 cm, at most about 4.5 cm, at most about 5 cm, or at most about 10 cm.

[0044] The lumen diameter of the secondary channel can also affect the flow of fluid through the vascular graft. In some embodiments, the vascular grafts disclosed herein have secondary channels with lumen diameters of about 1 cm to about 10 cm. In some embodiments, the vascular grafts disclosed herein have lumen diameters of about 1 cm to about 1.5 cm, about 1 cm to about 2 cm, about 1 cm to about 2.5 cm, about 1 cm to about 3 cm, about 1 cm to about 3.5 cm, about 1 cm to about 4 cm, about 1 cm to about 4.5 cm, about 1 cm to about 5 cm, about 1 cm to about 10 cm, about 1.5 cm to about 2 cm, about 1.5 cm to about 2.5 cm, about 1.5 cm to about 3 cm, about 1.5 cm to about 3.5 cm, about 1 cm to about 4 cm, about 1 cm to about 4.5 cm, about 1 cm to about 5 cm, about 1 cm to about 10 cm, about 1.5 cm to about 2 cm, about 1.5 cm to about 2.5 cm, about 1.5 cm to about 3 cm, about 1.5 cm to about 3.5 cm, about 1.5 cm to about 4 cm, about 1.5 cm to about 5 cm, about 1.5 cm to about 10 cm, about 2 cm to about 2.5 cm, about 2 cm to about 3 cm, about 2 cm to about 3.5 cm, about 2 cm to about 4 cm, about 2 cm to about 4.5 cm or about 5 cm to about 10 cm of secondary channel. In some embodiments, the vascular grafts disclosed herein have a secondary channel with a lumen diameter of about 1 cm, about 1.5 cm, about 2 cm, about 2.5 cm, about 3 cm, about 3.5 cm, about 4 cm, about 4.5 cm, about 5 cm, or about 10 cm. In some embodiments, the vascular grafts disclosed herein have a secondary channel with a lumen diameter of at least about 1 cm, at least about 1.5 cm, at least about 2 cm, at least about 2.5 cm, at least about 3 cm, at least about 3.5 cm, at least about 4 cm, at least about 4.5 cm, or at least about 5 cm. In some embodiments, the vascular grafts disclosed herein have a secondary channel with a lumen diameter of at most about 1.5 cm, at most about 2 cm, at most about 2.5 cm, at most about 3 cm, at most about 3.5 cm, at most about 4 cm, at most about 4.5 cm, at most about 5 cm, or at most about 10 cm.

[0045] The wall of the main channel or secondary channel may include an inner wall and an outer wall to form a void space in the channel. The thickness of the void space (also referred to as the channel wall thickness) may refer to the distance between the inner wall and the outer wall of the channel. In some embodiments, the channel wall thickness is from about 1 mm to about 2 cm. In some embodiments, the channel wall thickness of the primary channel or the secondary channel is about 1 mm to about 2 mm, about 1 mm to about 3 mm, about 1 mm to about 4 mm, about 1 mm to about 5 mm, about 1 mm to about 1 cm, about 1 mm to about 1.5 cm, about 1 mm to about 2 cm, about 2 mm to about 3 mm, about 2 mm to about 4 mm, about 2 mm to about 5 mm, about 2 mm to about 1 cm, about 2 mm to about 1.5 cm, about 2 mm to about 2 cm, about 3 mm to about 4 mm, about 3 mm to about 5 mm, about 3 mm to about 1 cm, about 3 mm to about 1.5 cm, about 3 mm to about 2 cm, about 4 mm to about 5 mm, about 4 mm to about 1 cm, about 4 mm to about 1.5 cm, about 4 mm to about 2 cm, about 5 mm to about 1 cm, about 5 mm to about 1.5 cm, about 5 mm to about 2 cm, about 1 cm to about 1.5 cm, about 1 cm to about 2 cm, or about 1.5 cm to about 2 cm. In some embodiments, the channel wall thickness of main channel or secondary channel is about 1mm, about 2mm, about 3mm, about 4mm, about 5mm, about 1cm, about 1.5cm or about 2cm. In some embodiments, the channel wall thickness of main channel or secondary channel is at least about 1mm, at least about 2mm, at least about 3mm, at least about 4mm, at least about 5mm, at least about 1cm or at least about 1.5cm. In some embodiments, the channel wall thickness of main channel or secondary channel is at most about 2mm, at most about 3mm, at most about 4mm, at most about 5mm, at most about 1cm, at most about 1.5cm or at most about 2cm.

[0046] The flow of fluid through the vascular graft may be affected by the lumen diameter of the microstructures forming the cylindrical tube. In some embodiments, the microstructures forming the cylindrical tube have a lumen diameter of about 1 mm to about 2 mm. In some embodiments, the microstructures forming the cylindrical tube have a lumen diameter of about 1 mm to about 1.1 mm, about 1 mm to about 1.2 mm, about 1 mm to about 1.3 mm, about 1 mm to about 1.4 mm, about 1 mm to about 1.5 mm, about 1 mm to about 1.6 mm, about 1 mm to about 1.7 mm, about 1 mm to about 1.8 mm, about 1 mm to about 1.9 mm, about 1 mm to about 2 mm, about 1.1 mm to about 1.2 mm, about 1.1 mm to about 1.3 mm, about 1.1 mm to about 1.4 mm, about 1.1 mm to about 1.5mm, about 1.1mm to about 1.6mm, about 1.1mm to about 1.7mm, about 1.1mm to about 1.8mm, about 1.1mm to about 1.9mm, about 1.1mm to about 2mm, about 1.2mm to about 1.3mm, about 1.2mm to about 1.4mm, about 1.2mm to about 1.5mm, about 1.2mm to about 1.6mm, about 1.2mm to about 1.7mm, about 1.2mm to about 1.8mm, about 1.2mm to about 1.9mm, about 1.2mm to about 2mm, about 1.3mm m to about 1.4 mm, about 1.3 mm to about 1.5 mm, about 1.3 mm to about 1.6 mm, about 1.3 mm to about 1.7 mm, about 1.3 mm to about 1.8 mm, about 1.3 mm to about 1.9 mm, about 1.3 mm to about 2 mm, about 1.4 mm to about 1.5 mm, about 1.4 mm to about 1.6 mm, about 1.4 mm to about 1.7 mm, about 1.4 mm to about 1.8 mm, about 1.4 mm to about 1.9 mm, about 1.4 mm to about 2 mm, about 1.5 mm to about 1.6 mm, about 1.4 mm to about 1.7 mm, about 1.4 mm to about 1.8 mm, about 1.4 mm to about 1.9 mm, about 1.4 mm to about 2 mm, about 1.5 mm to about 1.6 mm, about 1 In some embodiments, the microstructures forming the cylindrical tubes have a lumen diameter of about 1 mm, about 1.1 mm, about 1.2 mm, about 1.3 mm, about 1.4 mm, about 1.5 mm, about 1.6 mm, about 1.7 mm, about 1.8 mm, about 1.9 mm, about 1.6 mm to about 2 mm, about 1.7 mm to about 1.8 mm, about 1.7 mm to about 1.9 mm, about 1.7 mm to about 2 mm, about 1.8 mm to about 1.9 mm, about 1.8 mm to about 2 mm, or about 1.9 mm to about 2 mm. In some embodiments, the microstructures forming the cylindrical tubes have a lumen diameter of about 1 mm, about 1.1 mm, about 1.2 mm, about 1.3 mm, about 1.4 mm, about 1.5 mm, about 1.6 mm, about 1.7 mm, about 1.8 mm, about 1.9 mm, or about 2 mm.In some embodiments, the microstructures forming the cylindrical tubes have a lumen diameter of at least about 1 mm, at least about 1.1 mm, at least about 1.2 mm, at least about 1.3 mm, at least about 1.4 mm, at least about 1.5 mm, at least about 1.6 mm, at least about 1.7 mm, at least about 1.8 mm, or at least about 1.9 mm. In some embodiments, the microstructures forming the cylindrical tubes have a lumen diameter of at most about 1.1 mm, at most about 1.2 mm, at most about 1.3 mm, at most about 1.4 mm, at most about 1.5 mm, at most about 1.6 mm, at most about 1.7 mm, at most about 1.8 mm, at most about 1.9 mm, or at most about 2 mm.

[0047] The wall of the microstructure forming the cylindrical tube may include an inner wall and an outer wall. The distance from the inner wall of the microstructure forming the cylindrical tube to the outer wall may be referred to as the thickness of the wall. In some embodiments, the microstructure forming the cylindrical tube has a wall having a thickness of about 0.1 mm to about 1 mm. In some embodiments, the microstructure forming the cylindrical tube has a thickness of about 0.1 mm to about 0.2 mm, about 0.1 mm to about 0.3 mm, about 0.1 mm to about 0.4 mm, about 0.1 mm to about 0.5 mm, about 0.1 mm to about 0.6 mm, about 0.1 mm to about 0.7 mm, about 0.1 mm to about 0.8 mm, about 0.1 mm to about 0.9 mm, about 0.1 mm to about 1 mm, about 0.2 mm to about 0.3 mm, about 0.1 mm to about 0.4 mm, about 0.1 mm to about 0.5 mm, about 0.1 mm to about 0.6 mm, about 0.1 mm to about 0.7 mm, about 0.1 mm to about 0.8 mm, about 0.1 mm to about 0.9 mm, about 0.1 mm to about 1 mm, about 0.2 mm to about 0.3 mm m, about 0.2 mm to about 0.4 mm, about 0.2 mm to about 0.5 mm, about 0.2 mm to about 0.6 mm, about 0.2 mm to about 0.7 mm, about 0.2 mm to about 0.8 mm, about 0.2 mm to about 0.9 mm, about 0.2 mm to about 1 mm, about 0.3 mm to about 0.4 mm, about 0.3 mm to about 0.5 mm, about 0.3 mm to about 0.6 mm, about 0.3 mm to about 0.7 mm, about 0.3 ... m to about 0.8mm, about 0.3mm to about 0.9mm, about 0.3mm to about 1mm, about 0.4mm to about 0.5mm, about 0.4mm to about 0.6mm, about 0.4mm to about 0.7mm, about 0.4mm to about 0.8mm, about 0.4mm to about 0.9mm, about 0.4mm to about 1mm, about 0.5mm to about 0.6mm, about 0.5mm to about 0.7mm, about 0.5mm to about 0.8mm, In some embodiments, the microstructures forming the cylindrical tubes have a wall having a thickness of about 0.1 mm, about 0.2 mm, about 0.3 mm, about 0.4 mm, about 0.5 mm, about 0.6 mm, about 0.7 mm, about 0.8 mm, about 0.9 mm, about 0.6 mm to about 1 mm, about 0.7 mm to about 0.8 mm, about 0.7 mm to about 0.9 mm, about 0.7 mm to about 1 mm, about 0.8 mm to about 0.9 mm, about 0.8 mm to about 1 mm, or about 0.9 mm to about 1 mm. In some embodiments, the microstructures forming the cylindrical tubes have a wall having a thickness of about 0.1 mm, about 0.2 mm, about 0.3 mm, about 0.4 mm, about 0.5 mm, about 0.6 mm, about 0.7 mm, about 0.8 mm, about 0.9 mm, or about 1 mm. In some embodiments, the microstructures forming the cylindrical tubes have walls having a thickness of at least about 0.1 mm, at least about 0.2 mm, at least about 0.3 mm, at least about 0.4 mm, at least about 0.5 mm, at least about 0.6 mm, at least about 0.7 mm, at least about 0.8 mm, or at least about 0.9 mm.In some embodiments, the microstructures forming the cylindrical tubes have walls with a thickness of at most about 0.2 mm, at most about 0.3 mm, at most about 0.4 mm, at most about 0.5 mm, at most about 0.6 mm, at most about 0.7 mm, at most about 0.8 mm, at most about 0.9 mm, or at most about 1 mm.

[0048] In some embodiments, the wall of the main channel, the wall of the secondary channel, or the wall of the cylindrical tube forming the microstructure may comprise a microchannel. The microchannels in the wall of the main channel, the wall of the secondary channel, or the wall of the cylindrical tube forming the microstructure may be the same size or different sizes. In some embodiments, the diameter of the microchannel is from about 1 μm to about 1 mm. In some embodiments, the diameter of the microchannel is about 1 μm to about 10 μm, about 1 μm to about 50 μm, about 1 μm to about 100 μm, about 1 μm to about 200 μm, about 1 μm to about 300 μm, about 1 μm to about 400 μm, about 1 μm to about 500 μm, about 10 μm to about 50 μm, about 10 μm to about 100 μm, about 10 μm to about 200 μm, about 10 μm to about 300 μm, about 10 μm to about 400 μm, about 10 μm to about 500 μm, about 10 μm to about 1 mm, about 50 μm to about 100 μm, about 50 μm to about 200 μm, about 50 μm to about 300 μm, about 50 μm to about 400 μm, About 400μm, about 50μm to about 500μm, about 50μm to about 1mm, about 100μm to about 200μm, about 100μm to about 300μm, about 100μm to about 400μm, about 100μm to about 500μm, about 100μm to about 1mm, about 200μm to about 300μm, about 200μm to about 400μm, about 200μm to about 500μm, about 200μm to about 1mm, about 300μm to about 400μm, about 300μm to about 500μm, about 300μm to about 1mm, about 400μm to about 500μm, about 400μm to about 1mm or about 500μm to about 1mm. In some embodiments, the diameter of the microchannel is about 1 μm, about 10 μm, about 50 μm, about 100 μm, about 200 μm, about 300 μm, about 400 μm, about 500 μm, or about 1 mm. In some embodiments, the diameter of the microchannel is at least about 1 μm, at least about 10 μm, at least about 50 μm, at least about 100 μm, at least about 200 μm, at least about 300 μm, at least about 400 μm, or at least about 500 μm. In some embodiments, the diameter of the microchannel is at most about 10 μm, at most about 50 μm, at most about 100 μm, at most about 200 μm, at most about 300 μm, at most about 400 μm, at most about 500 μm, or at most about 1 mm.

[0049] Bioprinting

[0050] Disclosed herein is a method for printing a vascular graft. In some embodiments, printing is three-dimensional (3D) printing. In some embodiments, the method includes depositing the material onto a substrate via a needle by an extruder. The material may be a polymer material. In some embodiments, the polymer material is biocompatible and / or biodegradable. Non-limiting examples of polymer materials that can be deposited include polyesters, poly (α-hydroxy acids), polylactones, polyorthoesters, polycarbonates, polyanhydrides, polyphosphazenes, polycaprolactones (PCL), polylactic acid (PLA), poly-L-lactide-glycolic acid (PLGA), polyethylene glycol diacrylate (PEGDA), polyethylene glycol (PEG), poly (hydroxyethyl methacrylate) (PHEMA), polyvinyl alcohol (PVA), polyvinyl pyrrolidone (PVP), carboxymethyl cellulose (CMC), polyimide (PI), polyacrylate (PAA), polyurethane (PU), PEG-lactide and PEG-glycolide. In some embodiments, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or more polymeric materials are deposited. In some embodiments, a mixture of 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or more polymeric materials are deposited.

[0051] The methods of the present disclosure may include depositing an ECM material onto a substrate via an extrusion-based bioprinting process. In some embodiments, the ECM material and the polymer material are deposited. Non-limiting examples of ECM materials include Carrageenan, Carbomer, Chitosan, Sodium Alginate, Type I Collagen, Type III Collagen, Type IV Collagen, Type V Collagen, Type VI Collagen, Type VII Collagen, Type VIII Collagen, Type IX Collagen, Type X Collagen, Type XI Collagen, Type XII Collagen, Type XIII Collagen, Type XIV Collagen, Type XV Collagen, Type XVI Collagen, Type XVII Collagen, Type XVIII Collagen, Type XIX Collagen, Type X Type X collagen, type XXI collagen, type XXII collagen, type XXIII collagen, type XXIV collagen, type XXV collagen, type XXVI collagen, type XXVII collagen, type XXVIII collagen, type XXIX collagen, chondroitin sulfate, dextrose, fibrin, fibrinogen, gelatin, agar, methacryloyl gelatin, hyaluronic acid, heparin sulfate, laminin, polyethylene glycol, glycosaminoglycan (GAG), proteoglycan, or a combination thereof.

[0052] The methods of the present disclosure may include crosslinking the polymeric material. Crosslinking of the polymeric material may occur after deposition on the substrate or during deposition. Crosslinking of the polymeric material may include, for example, crosslinking with a free radical initiator, crosslinking with a thiol or amine moiety, and / or delivering a crosslinking agent to the polymeric material. Non-limiting examples of crosslinking agents include calcium (Ca 2+ ), magnesium (Mg 2+ ), calcium chloride, calcium sulfate, calcium carbonate, glutaraldehyde, genipin, nordihydroguaiaretic acid, tannic acid, proanthocyanidins, 1-ethyl-3-3-dimethylaminopropylcarbodiimide hydrochloride (EDC), divinylbenzene (DVB), ethylene glycol dimethacrylate (EGDMA), tetraethylene glycol diacrylate (TEGDA), polyethylene glycol diacrylate (PEGDA) and combinations thereof. In addition, the polymeric material can be crosslinked by exposure to light. In some embodiments, a photoinitiator is added to the polymeric material before crosslinking by exposure to light. Non-limiting examples of photoinitiators include (2-hydroxy-1-[4-(2-hydroxyethoxy)phenyl]-2-methyl-1-propanone; lithium phenyl-2,4,6-trimethylbenzoylphosphite (LAP); (2,2'-azobis[2-methyl-N-(2-hydroxyethyl)propionamide]; 2-isocyanatoethyl methacrylate; benzyl benzoylamide; camphorquinone; thiol-norbornene (thiol-ene); riboflavin; Lucirin-TPO; rose bengal / furfuryl; ethyl eosin; methacrylic anhydride; 2,2-dimethoxy-2-phenylacetophenone; and eosin Y.

[0053] In some embodiments, the methods of the present disclosure include depositing an ECM material mixed with cells so that the resulting vascular graft contains an ECM material embedded with cells. Non-limiting examples of cells that can be deposited with ECM materials include chondroblasts, chondrocytes, chondroprogenitor cells, chondrogenic precursors, keratinocytes, hair root cells, hair stem cells, hair matrix cells, exocrine secretory epithelial cells, hormone secreting cells, epithelial cells, neural or sensory cells, photoreceptor cells, muscle cells, extracellular matrix cells, blood cells, cardiovascular cells, endothelial cells, vascular smooth muscle cells, kidney cells, pancreatic cells, immune cells, stem cells, germ cells, mesenchymal cells, stellate cells, hepatocytes, gastrointestinal cells, lung cells, tracheal cells, vascular cells, skeletal muscle cells, cardiomyocytes, skin cells, smooth muscle cells, connective tissue cells, corneal cells, urogenital cells, mammary gland cells, ovarian cancer ... Glandular cells, germ cells, endothelial cells, epithelial cells, fibroblasts, Schwann cells, adipocytes, bone cells, bone marrow cells, chondrocytes, pericytes, mesothelial cells, endocrine tissue-derived cells, stromal cells, progenitor cells, lymphocytes, endoderm-derived cells, ectoderm-derived cells, mesoderm-derived cells, pericytes, chondroblasts, mesenchymal stem cells, connective tissue fibroblasts, tendon fibroblasts, bone marrow reticular tissue fibroblasts, non-epithelial fibroblasts, pericytes, osteoprogenitor cells, osteoblasts, osteoclasts, articular chondrocytes, stem cells, progenitor cells, totipotent cells, pluripotent stem cells, multipotent stem cells, induced pluripotent stem cells, and cells derived from any of the above cells.

[0054] In some embodiments, the method of the present disclosure includes printing a vascular graft in the form of a hollow cylindrical tube containing a plurality of living cells embedded in an ECM material. For example, the method may include depositing a polymer material, various types of living cells, and an ECM material in layers on or within a substrate. The substrate may be, for example, a dish, a culture dish, a tissue culture plate, a cell culture flask, a peeling bottle, a jar, or a washable chip.

[0055] The methods of the present disclosure can print vascular grafts comprising channel walls having microchannels. The microchannels can be generated using fugitive inks. Non-limiting examples of fugitive inks include F-127 (PF127), gelatin, and carbohydrate glass. Fugitive inks are inks designed to be removed upon introduction of a stimulus, such as immersion in a liquid, an increase in temperature, or a decrease in temperature. In some embodiments, the methods disclosed herein include printing a fugitive ink into a material and then removing the fugitive ink by immersing the material in an aqueous solution, thereby leaving behind microchannels. F127 is composed of one hydrophobic poly(propylene oxide) (PPO) segment and two hydrophilic poly(ethylene oxide) (PEO) segments in a PEO-PPO-PEO configuration.

[0056] Microchannels can be generated by, for example, pre-printing a polymer material such as PCL with a fugitive ink, or by first printing a polymer material and then printing the fugitive ink on top. In some embodiments, PCL and PF127 are printed together, and then cells are added to the polymer material composed of LAP and In some embodiments, PCL and PF127 are printed together, and LAP and PF127 are printed together. In some embodiments, PCL is printed alone, PF127 is added to the PCL, and then LAP and PF127 are printed. In some embodiments, PCL and and cells, and PF127 was subsequently added as a top layer along with the cell-infused LAP.

[0057] Bioprinting parameters

[0058] The methods disclosed herein can use needles for bioprinting processes. In some embodiments, one or more polymer materials, fugitive inks, ECM materials, cell suspensions, or combinations thereof are deposited onto a substrate through a needle. The methods of the present disclosure can print from more than one needle, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or more needles. In some embodiments, the needles used in the methods disclosed herein have a diameter expressed using the Birmingham gauge system. In some embodiments, the needle has a diameter of 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 22s, 23, 24, 25, 26, 26s, 27, 28, 29, 30, 31, 32, 33, or 34.

[0059] In some embodiments, the diameter of the needle of the present disclosure is between 0.1 mm and 400 mm. In some embodiments, the diameter of the needle of the present disclosure is between 0.1 mm and 0.5 mm, between 0.1 mm and 1 mm, between 0.1 mm and 10 mm, between 0.1 mm and 20 mm, between 0.1 mm and 30 mm, between 0.1 mm and 40 mm, between 0.1 mm and 50 mm, between 0.1 mm and 100 mm, between 0.1 mm and 200 mm, between 0.1 mm and 300 mm, between 0.1 mm and 400 mm, between 0.5 mm and 1 mm, between 0.5 mm and 10 mm, between 0.5 mm and 20 mm, between 0.5 mm and 30 mm, between 0.5mm to 40mm, 0.5mm to 50mm, 0.5mm to 100mm, 0.5mm to 200mm, 0.5mm to 300mm, 0.5mm to 400mm, 1mm to 10mm, 1mm to 20mm, 1mm to 30mm, 1mm to 40mm, 1mm to 50mm, 1mm to 100mm, 1mm to 200mm, 1mm to 300mm, 1mm to 400mm, 10mm to 20mm, 10mm to 30mm, 10mm to 40 mm, between 10mm and 50mm, between 10mm and 100mm, between 10mm and 200mm, between 10mm and 300mm, between 10mm and 400mm, between 20mm and 30mm, between 20mm and 40mm, between 20mm and 50mm, between 20mm and 100mm, between 20mm and 200mm, between 20mm and 300mm, between 20mm and 400mm, between 30mm and 40mm, between 30mm and 50mm, between 30mm and 100mm, between 30mm and 200mm, between 30mm and 300mm m, between 30mm and 400mm, between 40mm and 50mm, between 40mm and 100mm, between 40mm and 200mm, between 40mm and 300mm, between 40mm and 400mm, between 50mm and 100mm, between 50mm and 200mm, between 50mm and 300mm, between 50mm and 400mm, between 100mm and 200mm, between 100mm and 300mm, between 100mm and 400mm, between 200mm and 300mm, between 200mm and 400mm or between 300mm and 400mm.In some embodiments, the diameter of the needle of the present disclosure is 0.1mm, 0.5mm, 1mm, 10mm, 20mm, 30mm, 40mm, 50mm, 100mm, 200mm, 300mm, or 400mm. In some embodiments, the diameter of the needle of the present disclosure is at least 0.1mm, at least 0.5mm, at least 1mm, at least 10mm, at least 20mm, at least 30mm, at least 40mm, at least 50mm, at least 100mm, at least 200mm, or at least 300mm. In some embodiments, the diameter of the needle of the present disclosure is at most 0.5mm, at most 1mm, at most 10mm, at most 20mm, at most 30mm, at most 40mm, at most 50mm, at most 100mm, at most 200mm, at most 300mm, or at most 400mm.

[0060] The methods of the present disclosure can deposit a mixture of injected cells. The mixture of injected cells of the present disclosure can have a cell density of, for example, about 1 cell / pL, about 10 cells / pL, about 100 cells / pL, about 1 cell / nL, about 10 cells / nL, about 100 cells / nL, about 1 cell / μL, about 10 cells / μL, about 100 cells / μL, about 1000 cells / μL, about 10,000 cells / μL, about 100,000 cells / μL. In some embodiments, the cell density of the mixture of injected cells of the present disclosure is about 2x10 6 cells / mL, about 3x10 6 cells / mL, about 4x10 6 cells / mL, about 5x10 6 cells / mL, about 6x10 6 cells / mL, about 7x10 6 cells / mL, about 8x10 6 cells / mL, about 9x10 6 cells / mL, about 10x10 6 cells / mL, about 15x10 6 cells / mL, about 20x10 6 cells / mL, about 25x10 6 cells / mL, about 30x10 6 cells / mL, about 35x10 6 cells / mL, about 40x10 6 cells / mL, about 45x10 6 cells / mL or about 50x10 6Cells / mL. The mixture of injected cells can include one or more cell types. For example, in some embodiments, the mixture of injected cells of the present disclosure contains 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 13, 14, 15 or more cell types.

[0061] In some embodiments, the methods of the present disclosure can generate vascular grafts by printing multiple layers. For example, the methods of the present disclosure can print a layer of polymer material, a layer of ECM material, a layer of injected cells, a layer of ECM injected cells, a layer of fugitive ink, and / or a layer comprising a combination of any of the foregoing. In some embodiments, the method includes printing 2 layers, 3 layers, 4 layers, 5 layers, 6 layers, 7 layers, 8 layers, 9 layers, 10 layers, 20 layers, 30 layers, 40 layers, 50 layers, 100 layers or more layers. In some embodiments, the thickness of each layer is about 0.01 mm to about 10 mm. In some embodiments, the thickness of each layer is from about 0.01 mm to about 0.05 mm, from about 0.01 mm to about 0.1 mm, from about 0.01 mm to about 0.25 mm, from about 0.01 mm to about 0.5 mm, from about 0.01 mm to about 1 mm, from about 0.01 mm to about 2 mm, from about 0.01 mm to about 3 mm, from about 0.01 mm to about 4 mm, from about 0.01 mm to about 5 mm, from about 0.01 mm to about 10 mm, from about 0.05 mm to about 0.1 mm, from about 0.05 mm to about mm to about 0.25 mm, about 0.05 mm to about 0.5 mm, about 0.05 mm to about 1 mm, about 0.05 mm to about 2 mm, about 0.05 mm to about 3 mm, about 0.05 mm to about 4 mm, about 0.05 mm to about 5 mm, about 0.05 mm to about 10 mm, about 0.1 mm to about 0.25 mm, about 0.1 mm to about 0.5 mm, about 0.1 mm to about 1 mm, about 0.1 mm to about 2 mm, about 0.1 mm to about 3 mm, about 0.1 mm to about 4 mm. to about 4 mm, about 0.1 mm to about 5 mm, about 0.1 mm to about 10 mm, about 0.25 mm to about 0.5 mm, about 0.25 mm to about 1 mm, about 0.25 mm to about 2 mm, about 0.25 mm to about 3 mm, about 0.25 mm to about 4 mm, about 0.25 mm to about 5 mm, about 0.25 mm to about 10 mm, about 0.5 mm to about 1 mm, about 0.5 mm to about 2 mm, about 0.5 mm to about 3 mm, about 0.5 mm to about 4 mm, about 0.25 mm to about 5 mm, about 0.25 mm to about 10 mm, about 0.5 mm to about 1 mm, about 0.5 mm to about 2 mm, about 0.5 mm to about 3 mm, about 0.5 mm to about 4 mm, about 0. In some embodiments, the thickness of each layer is about 0.01 mm, about 0.05 mm, about 0.1 mm, about 0.25 mm, about 0.5 mm, about 1 mm, about 2 mm, about 3 mm, about 4 mm, about 5 mm, about 1 mm to about 10 mm, about 2 mm to about 3 mm, about 2 mm to about 4 mm, about 2 mm to about 5 mm, about 2 mm to about 10 mm, about 3 mm to about 4 mm, about 3 mm to about 5 mm, about 3 mm to about 10 mm, about 4 mm to about 5 mm, about 4 mm to about 10 mm, or about 5 mm to about 10 mm. In some embodiments, the thickness of each layer is about 0.01 mm, about 0.05 mm, about 0.1 mm, about 0.25 mm, about 0.5 mm, about 1 mm, about 2 mm, about 3 mm, about 4 mm, about 5 mm, or about 10 mm.In some embodiments, the thickness of each layer is at least about 0.01 mm, at least about 0.05 mm, at least about 0.1 mm, at least about 0.25 mm, at least about 0.5 mm, at least about 1 mm, at least about 2 mm, at least about 3 mm, at least about 4 mm, or at least about 5 mm. In some embodiments, the thickness of each layer is at most about 0.05 mm, at most about 0.1 mm, at most about 0.25 mm, at most about 0.5 mm, at most about 1 mm, at most about 2 mm, at most about 3 mm, at most about 4 mm, at most about 5 mm, or at most about 10 mm.

[0062] Method disclosed herein may include using an extruder to pass material through a needle and arrive on a substrate. In some embodiments, a plurality of extruders deposit one or more materials onto a substrate. For example, a plurality of extruders can deposit materials simultaneously, sequentially or in a predetermined order. In some embodiments, the deposition from one or more extruders is controlled in real time. In some embodiments, print with 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or more extruders.

[0063] The temperature at which the extruder operates can be controlled. In some embodiments, the extruder is operated at a temperature of about 25°C to about 200°C. In some embodiments, the extruder is operated at a temperature of about 25°C to about 37°C, about 25°C to about 50°C, about 25°C to about 75°C, about 25°C to about 100°C, about 25°C to about 150°C, about 25°C to about 200°C, about 27°C to about 37°C, about 27°C to about 50°C, about 27°C to about 75°C, about 27°C to about 100°C, about 27°C to about 150°C, about 27°C to about 200°C, about 37°C to about 50°C, about 37°C to about In some embodiments, the extruder is operated at a temperature of about 25° C., about 27° C., about 37° C., about 50° C., about 75° C., about 100° C., about 150° C., about 37° C. to about 200° C., about 50° C. to about 75° C., about 50° C. to about 100° C., about 50° C. to about 150° C., about 50° C. to about 200° C., about 75° C. to about 100° C., about 75° C. to about 150° C., about 75° C. to about 200° C., about 100° C. to about 150° C., about 100° C. to about 200° C., or about 150° C. to about 200° C. In some embodiments, the extruder is operated at a temperature of about 25° C., about 27° C., about 37° C., about 50° C., about 75° C., about 100° C., about 150° C., or about 200° C. In some embodiments, the extruder is operated at a temperature of at least about 25° C., at least about 27° C., at least about 37° C., at least about 50° C., at least about 75° C., at least about 100° C., or at least about 150° C. In some embodiments, the extruder is operated at a temperature of at most about 25° C., at most about 37° C., at most about 50° C., at most about 75° C., at most about 100° C., at most about 150° C., or at most about 200° C.

[0064] In some embodiments, pressurized air is used to move the material through the extruder. The air pressure of the extruder can be controlled. In some embodiments, the extruder operates at an air pressure of about 600 kPa to about 800 kPa. In some embodiments, the extruder is operated at a pressure of about 600 kPa to about 625 kPa, about 600 kPa to about 650 kPa, about 600 kPa to about 675 kPa, about 600 kPa to about 700 kPa, about 600 kPa to about 725 kPa, about 600 kPa to about 750 kPa, about 600 kPa to about 775 kPa, about 600 kPa to about 800 kPa, about 625 kPa to about 650 kPa, about 625 kPa to about 675 kPa, about 625 kPa to about 700 kPa, about 625 kPa to about 725 kPa, about 625 kPa to about 750 kPa, about 625 kPa to about 775 kPa, about 625 kPa to about 800 kPa, about 650 kPa to about 675 kPa, about 650 kPa to about 700 kPa, about 650 kPa to about 725 kPa kPa, about 650 kPa to about 750 kPa, about 650 kPa to about 775 kPa, about 650 kPa to about 800 kPa, about 675 kPa to about 700 kPa, about 675 kPa to about 725 kPa, about 675 kPa to about 750 kPa, about 675 kPa to about 775 kPa, about 675 kPa to about 800 kPa, about 700 kPa to about 725 kPa, about 700 kPa to about 750 kPa, about 700 kPa to about 775 kPa, about 700 kPa to about 800 kPa, about 725 kPa to about 750 kPa, about 725 kPa to about 775 kPa, about 725 kPa to about 800 kPa, about 750 kPa to about 775 kPa, about 750 kPa to about 800 kPa, or about 775 kPa to about 800 kPa. In some embodiments, the extruder is operated at a gas pressure of about 600 kPa, about 625 kPa, about 650 kPa, about 675 kPa, about 689.5 kPa, about 700 kPa, about 717.1 kPa, about 725 kPa, about 750 kPa, about 775 kPa, or about 800 kPa. In some embodiments, the extruder is operated at a gas pressure of at least about 600 kPa, at least about 625 kPa, at least about 650 kPa, at least about 675 kPa, at least about 700 kPa, at least about 725 kPa, at least about 750 kPa, or at least about 775 kPa. In some embodiments, the extruder is operated at a gas pressure of at most about 625 kPa, at most about 650 kPa, at most about 675 kPa, at most about 700 kPa, at most about 725 kPa, at most about 750 kPa, at most about 775 kPa, or at most about 800 kPa.

[0065] In some embodiments, the extruder is operated at a gas pressure of about 87 pounds per square inch (psi) to about 116 psi. In some embodiments, the extruder is operated at about 87 psi to about 90.6 psi, about 87 psi to about 94.3 psi, about 87 psi to about 97.9 psi, about 87 psi to about 101.5 psi, about 87 psi to about 105.2 psi, about 87 psi to about 108.8 psi, about 87 psi to about 112.4 psi, about 87 psi to about 116 psi, about 90.6 psi to about 94.3 psi, about 90.6 psi to about 97.9 psi, about 90.6 psi to about 101.5 psi, about 90.6 psi to about 105.2 psi, about 90.6 psi to about 108.8 psi, about 90.6 psi to about 112.4 psi, about 90.6 psi to about 116 psi, about 94.3 psi to about 97.9 psi, about 94.3 psi to about 101.5 psi, about 94.3 psi to about 105.2 psi, about 94.3 psi to about 108.8 psi, about 94.3 psi to about 116 psi to about 108.8 psi, about 94.3 psi to about 112.4 psi, about 94.3 psi to about 116 psi, about 97.9 psi to about 101.5 psi, about 97.9 psi to about 105.2 psi, about 97.9 psi to about 108.8 psi, about 97.9 psi to about 112.4 psi, about 97.9 psi to about 116 psi, about 101.5 psi to about 105.2 psi, about 101.5 psi In some embodiments, the extruder is operated at a gas pressure of about 87 psi, about 90.6 psi, about 94.3 psi, about 97.9 psi, about 100 psi, about 101.5 psi, about 104 psi, about 105.2 psi, about 108.8 psi, about 112.4 psi, about 116 psi, about 108.8 psi, about 112.4 psi, about 105.2 psi to about 116 psi, about 108.8 psi to about 112.4 psi, about 108.8 psi to about 116 psi, or about 112.4 psi to about 116 psi. In some embodiments, the extruder is operated at a gas pressure of about 87 psi, about 90.6 psi, about 94.3 psi, about 97.9 psi, about 100 psi, about 101.5 psi, about 104 psi, about 105.2 psi, about 108.8 psi, about 112.4 psi, or about 116 psi. In some embodiments, the extruder is operated at a gas pressure of at least about 87 psi, at least about 90.6 psi, at least about 94.3 psi, at least about 97.9 psi, at least about 101.5 psi, at least about 105.2 psi, at least about 108.8 psi, or at least about 112.4 psi.In some embodiments, the extruder is operated at a gas pressure of up to about 90.6 psi, up to about 94.3 psi, up to about 97.9 psi, up to about 101.5 psi, up to about 105.2 psi, up to about 108.8 psi, up to about 112.4 psi, or up to about 116 psi.

[0066] The methods of the present disclosure may include printing materials at various linear extrusion speeds. In some embodiments, the material is deposited at a linear extrusion speed of about 100 mm / s to about 800 mm / s. In some embodiments, the material is deposited at a linear extrusion speed of about 100 mm / s to about 150 mm / s, about 100 mm / s to about 200 mm / s, about 100 mm / s to about 250 mm / s, about 100 mm / s to about 300 mm / s, about 100 mm / s to about 350 mm / s, about 100 mm / s to about 400 mm / s, about 100 mm / s to about 450 mm / s, about 100 mm / s to about 500 mm / s, about 100 mm / s to about 600 mm / s, about 100 mm / s to about 700 mm / s, about 100 mm / s to about 800 mm / s, about 150 mm / s to about 200 mm / s, about 150 mm / s to about mm / s to about 250 mm / s, about 150 mm / s to about 300 mm / s, about 150 mm / s to about 350 mm / s, about 150 mm / s to about 400 mm / s, about 150 mm / s to about 450 mm / s, about 150 mm / s to about 500 mm / s, about 150 mm / s to about 600 mm / s, about 150 mm / s to about 700 mm / s, about 150 mm / s to about 800 mm / s, about 200 mm / s to about 250 mm / s, about 200 mm / s to about 300 mm / s, about 200 mm / s to about 350 mm / s, about 200 mm / s to about 400 mm / s, about 20 0mm / s to about 450mm / s, about 200mm / s to about 500mm / s, about 200mm / s to about 600mm / s, about 200mm / s to about 700mm / s, about 200mm / s to about 800mm / s, about 250mm / s to about 300mm / s, about 250mm / s to about 350mm / s, about 250mm / s to about 400mm / s, about 250mm / s to about 450mm / s, about 250mm / s to about 500mm / s, about 250mm / s to about 600mm / s, about 250mm / s to about 700mm / s, about 250mm / s to about 800mm / s, about 300mm / s to about 350mm / s, about 300mm / s to about 400mm / s, about 300mm / s to about 450mm / s, about 300mm / s to about 500mm / s, about 300mm / s to about 600mm / s, about 300mm / s to about 700mm / s, about 300mm / s to about 800mm / s, about 350mm / s to about 400mm / s, about 350mm / s to about 450mm / s, about 350mm / s to about 500mm / s, about 350mm / s to about 600mm / s, about 350mm / s to about 700mm / s, about 350mm / s to about 800mm / s,The linear extrusion speed is deposited at about 400 mm / s to about 450 mm / s, about 400 mm / s to about 500 mm / s, about 400 mm / s to about 600 mm / s, about 400 mm / s to about 700 mm / s, about 400 mm / s to about 800 mm / s, about 450 mm / s to about 500 mm / s, about 450 mm / s to about 600 mm / s, about 450 mm / s to about 700 mm / s, about 450 mm / s to about 800 mm / s, about 500 mm / s to about 600 mm / s, about 500 mm / s to about 700 mm / s, about 500 mm / s to about 800 mm / s, about 600 mm / s to about 700 mm / s, about 600 mm / s to about 800 mm / s, or about 700 mm / s to about 800 mm / s. In some embodiments, the material is deposited at a linear extrusion speed of about 100 mm / s, about 150 mm / s, about 200 mm / s, about 250 mm / s, about 300 mm / s, about 350 mm / s, about 400 mm / s, about 450 mm / s, about 500 mm / s, about 600 mm / s, about 700 mm / s, or about 800 mm / s. In some embodiments, the material is deposited at a linear extrusion speed of at least about 100 mm / s, at least about 150 mm / s, at least about 200 mm / s, at least about 250 mm / s, at least about 300 mm / s, at least about 350 mm / s, at least about 400 mm / s, at least about 450 mm / s, at least about 500 mm / s, at least about 600 mm / s, or at least about 700 mm / s. In some embodiments, the material is deposited at a linear extrusion speed of up to about 150 mm / s, up to about 200 mm / s, up to about 250 mm / s, up to about 300 mm / s, up to about 350 mm / s, up to about 400 mm / s, up to about 450 mm / s, up to about 500 mm / s, up to about 600 mm / s, up to about 700 mm / s, or up to about 800 mm / s.

[0067] The methods of the present disclosure may include printing material at various volumetric rates. In some embodiments, printing is performed at a volumetric rate of about 1 μL / s to about 100 μL / s. In some embodiments, the flow rate is from about 1 μL / s to about 5 μL / s, from about 1 μL / s to about 10 μL / s, from about 1 μL / s to about 15 μL / s, from about 1 μL / s to about 20 μL / s, from about 1 μL / s to about 25 μL / s, from about 1 μL / s to about 50 μL / s, from about 1 μL / s to about 100 μL / s, from about 5 μL / s to about 10 μL / s, from about 5 μL / s to about 15 μL / s, from about 5 μL / s to about 20 μL / s, from about 5 μL / s to about 25 μL / s, from about 5 μL / s to about 50 μL / s, from about 5 μL / s to about 100 μL / s, from about 10 μL / s to about 15 μL / s, from about 10 μL / s to about Printing is performed at a volumetric speed of about 20 μL / s, about 10 μL / s to about 25 μL / s, about 10 μL / s to about 50 μL / s, about 10 μL / s to about 100 μL / s, about 15 μL / s to about 20 μL / s, about 15 μL / s to about 25 μL / s, about 15 μL / s to about 50 μL / s, about 15 μL / s to about 100 μL / s, about 20 μL / s to about 25 μL / s, about 20 μL / s to about 50 μL / s, about 20 μL / s to about 100 μL / s, about 25 μL / s to about 50 μL / s, about 25 μL / s to about 100 μL / s, or about 50 μL / s to about 100 μL / s. In some embodiments, printing is performed at a volumetric speed of about 1 μL / s, about 5 μL / s, about 10 μL / s, about 15 μL / s, about 20 μL / s, about 25 μL / s, about 50 μL / s, or about 100 μL / s. In some embodiments, printing is performed at a volumetric speed of at least about 1 μL / s, at least about 5 μL / s, at least about 10 μL / s, at least about 15 μL / s, at least about 20 μL / s, at least about 25 μL / s, or at least about 50 μL / s. In some embodiments, printing is performed at a volumetric speed of at most about 5 μL / s, at most about 10 μL / s, at most about 15 μL / s, at most about 20 μL / s, at most about 25 μL / s, at most about 50 μL / s, or at most about 100 μL / s.

[0068] The methods of the present disclosure may include controlling the deposition of materials at a certain resolution. In some embodiments, the methods disclosed herein may control the deposition of materials at a resolution of about 0.01 mm to about 1 mm. In some embodiments, the methods disclosed herein may control the deposition of materials at a resolution of about 0.01 mm to about 0.05 mm, about 0.01 mm to about 0.1 mm, about 0.01 mm to about 0.2 mm, about 0.01 mm to about 0.3 mm, about 0.01 mm to about 0.4 mm, about 0.01 mm to about 0.5 mm, about 0.01 mm to about 1 mm, about 0.05 mm to about 0.1 mm, about 0.05 mm to about 0.2 mm, about 0.05 mm to about 0.3 mm, about 0.05 mm to about 0.4 mm, about 0.05 mm to about 0.5 mm, about 0.05 mm to about 1 mm , about 0.1 mm to about 0.2 mm, about 0.1 mm to about 0.3 mm, about 0.1 mm to about 0.4 mm, about 0.1 mm to about 0.5 mm, about 0.1 mm to about 1 mm, about 0.2 mm to about 0.3 mm, about 0.2 mm to about 0.4 mm, about 0.2 mm to about 0.5 mm, about 0.2 mm to about 1 mm, about 0.3 mm to about 0.4 mm, about 0.3 mm to about 0.5 mm, about 0.3 mm to about 1 mm, about 0.4 mm to about 0.5 mm, about 0.4 mm to about 1 mm, or about 0.5 mm to about 1 mm. In some embodiments, the methods disclosed herein can control the deposition of materials with a resolution of about 0.01 mm, about 0.05 mm, about 0.1 mm, about 0.2 mm, about 0.3 mm, about 0.4 mm, about 0.5 mm, or about 1 mm. In some embodiments, the methods disclosed herein can control material deposition at a resolution of at least about 0.01 mm, at least about 0.05 mm, at least about 0.1 mm, at least about 0.2 mm, at least about 0.3 mm, at least about 0.4 mm, or at least about 0.5 mm. In some embodiments, the methods disclosed herein can control material deposition at a resolution of at most about 0.05 mm, at most about 0.1 mm, at most about 0.2 mm, at most about 0.3 mm, at most about 0.4 mm, at most about 0.5 mm, or at most about 1 mm.

[0069] Computer Systems

[0070] Bioprinting parameters such as deposition rate, extruder pressure, extruder temperature, extruder deposition mode, deposition position, layer thickness, and deposited material can be controlled by a computer system. In some embodiments, the computer system includes a processor, a storage device, an operating system, and a software module for monitoring or operating the extruder. In some embodiments, the computer system includes a digital processing device and includes one or more hardware central processing units (CPUs). In other embodiments, the computer system includes an operating system configured to execute executable instructions. In some embodiments, an operating system is software including programs and data that manages the hardware of the device and provides services for executing applications. As non-limiting examples, suitable server operating systems include FreeBSD, OpenBSD, Linux, Mac OS X Windows and By way of non-limiting example, suitable personal computer operating systems include Mac OS and UNIX-like operating systems such as In some embodiments, the operating system is provided by cloud computing. In some embodiments, a mobile smartphone operating system is used. Non-limiting examples of mobile smartphone operating systems include OS, Research In BlackBerry Google° Windows OS, Windows OS, Linux, and WebOS. In some embodiments, the computer system includes a storage and / or memory device. In some embodiments, the storage and / or memory device is one or more physical devices for temporarily or permanently storing data or programs. In some embodiments, the device is a volatile memory and requires power to maintain the stored information. In some embodiments, the device is a non-volatile memory and retains the stored information when the digital processing device is not powered on. In other embodiments, the non-volatile memory includes flash memory. In some embodiments, the non-volatile memory includes a dynamic random access memory (DRAM). In some embodiments, the non-volatile memory includes a ferroelectric random access memory (FRAM). In some embodiments, the non-volatile memory includes a phase change random access memory (PRAM). In some embodiments, the device is a storage device, which includes, as a non-limiting example, a CD-ROM, a DVD, a flash memory device, a disk drive, a tape drive, an optical drive, and a cloud computing-based storage. In some embodiments, the storage and / or memory device is a combination of devices such as those disclosed herein.

[0071] In some embodiments, the computer system described herein includes a user interface. In other embodiments, the user interface includes a graphical user interface (GUI), such as a Repetier-Host graphical user interface. In other embodiments, the user interface is interactive, and menus and options are presented to the user for interacting with the computer system and delivery system herein. In other embodiments, the computer system includes a display screen to send visual information to the user. In some embodiments, the display is a cathode ray tube (CRT). In some embodiments, the display is a liquid crystal display (LCD). In other embodiments, the display is a thin film transistor liquid crystal display (TFT-LCD). In some embodiments, the display is an organic light emitting diode (OLED) display. In some embodiments, the OLED display is a passive matrix OLED (PMOLED) or an active matrix OLED (AMOLED) display. In some embodiments, the display is a plasma display. In some embodiments, the display is a video projector. In some embodiments, the display is a combination of displays such as those disclosed herein. In some embodiments, the device includes an input device for receiving information from a user. In some embodiments, the input device is a keyboard. In some embodiments, the input device is a keypad. In some embodiments, the input device is a display screen, which is a touch screen or a multi-touch screen. In some embodiments, the input device is a microphone to capture voice or other sound input. In some embodiments, the system and software module disclosed herein are based on an intranet. In some embodiments, the system and software module are based on the Internet. In some embodiments, the computer system and software module are based on the World Wide Web. In some embodiments, the computer system and software module are based on cloud computing. In some embodiments, the computer system and software module are based on data storage devices, as non-limiting examples, including CD-ROM, DVD, flash memory devices, RAM (e.g., DRAM, SRAM, etc.), ROM (e.g., ROM, EPROM, EEPROM, etc.), tape drives, disk drives, optical disk drives, magneto-optical drives, solid-state drives and combinations thereof.

[0072] Example

[0073] Example 1: Vascular structure with bifurcated main channel

[0074] Figure 1 The schematic diagram shown in Figure 1 shows a cross-sectional view of a main channel. The lumen of the channel is formed by a channel wall, which is composed of a polymeric material. The channel wall includes an inner wall and an outer wall to create a void space within the channel wall. Figure 1 It can also be seen that the void space is filled with cells that can be used to culture living cells. The main channel contains bifurcations and forms vascular structures. Figure 2 The schematic diagram shown in shows a cross-sectional view of a vascular construct having a bifurcated main channel.

[0075] Example 2: Branched vascular structure with bifurcated main channel

[0076] Figure 3 Schematic diagram showing a cross-sectional view of a vascular construct containing a bifurcated main channel from which multiple branches emanate. The wall of the main channel is composed of PCL. At the end of each branch is a stem cell spheroid. The branch wall is composed of surrounding The PCL of the central core and the injected cells The mixture composition is Figure 4 Shown Alternatively, the branch wall is formed by surrounding The PCL composition of the central core is as follows Figure 5 shown.

[0077] Example 3: Microstructure design of channel wall

[0078] The main channel is formed by walls containing a honeycomb microstructure. A schematic diagram of the honeycomb microstructure is shown in Figure 6 The microstructure is formed by six hollow cylindrical PCL tubes connected in a hexagonal form around a central PCL tube. Some tubes of the microstructure contain microchannels and triangular substructures within the hollow space of the tube, such as Figure 7 As shown. Printed in the triangular substructure and inside the hollow space of the tube.

[0079] Example 4: Cylindrical tube with microchannels

[0080] Figure 8 A schematic diagram of a cross-sectional view of a cylindrical tube forming the main channel wall is shown. The tube contains microchannels (represented by small circles). The tube has an outer diameter of about 3.3 cm, an inner diameter of about 2.5 cm, a thickness of about 0.4 cm, a distance from the inner wall to the center of about 1.3 cm, a distance from the outer wall to the center of about 1.7 cm, and a height of about 4 cm.

[0081] Example 5: Bioprinting of Vascular Grafts

[0082] The vascular grafts were printed using an extrusion-based bioprinting process. The STL file was created using a computer-aided design (CAD) program combined with G-code. The STL file contained the design for the vascular graft and was created using the Repetier-Host graphical user interface. The multi-syringe-based extruder used air compression to move the plunger from a 10 mL syringe at 10 micron resolution. The tip was a needle. Each extruder was individually controlled by software and had separate control over properties such as deposit size, deposit speed, and extrusion temperature.

[0083] Vascular grafts were printed onto peel flasks. The PCL-PF127 mixture was used to print a vascular graft having a hollow cylindrical tube containing a main channel with multiple cylindrical branches extending from the main channel. The cylindrical channel walls contained microstructures generated using a fugitive ink composed of PF127. Pluripotent stem cells were then added to the LAP and The mixture was deposited as a layer on the wall of the cylindrical branches. The pluripotent stem cell spheroids attached to the distal ends of the cylindrical branches. The vascular grafts were immersed in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum and 1% penicillin / streptomycin for one week to culture the cells. Cell viability was measured using The test was performed. Vascular grafts immersed in methanol were used as a positive control for cell death. As a negative control for cell death, cells were cultured on tissue culture plastic. The number of cells seeded on tissue culture plastic was the same as the number of cells deposited in the vascular grafts.

[0084] Example 6 Implantation of Vascular Graft

[0085] Will The mixture was used to print a vascular graft with a hollow cylindrical tube containing a single main channel. The channel walls contained endothelial cells embedded in the void space. The vascular graft is cultured for one week. After the graft has been cultured, the vascular graft is implanted into a patient who has atherosclerotic plaque buildup in their coronary arteries. The patient is anesthetized. An incision is made in the patient's chest, and the sternum is cut to provide access to the heart. The patient is then placed on a heart-lung machine during surgery. A blood vessel upstream of the atherosclerotic plaque buildup is severed and attached to one end of the vascular graft. A second portion of a blood vessel downstream of the atherosclerotic plaque buildup is severed and connected to the other end of the vascular graft, allowing blood flow to bypass the blockage caused by the atherosclerotic plaque. Implantation of the vascular graft improves blood flow to the patient's heart muscle and reduces the risk of a heart attack.

[0086] Implementation

[0087] The following non-limiting embodiments provide illustrative examples of the methods and systems disclosed in the present disclosure, but do not limit the scope of the methods and systems of the present disclosure.

[0088] Embodiment 1. A vascular graft comprising a hollow cylinder, wherein the hollow cylinder comprises a first opening and a second opening, and wherein the hollow cylinder comprises: (a) a main channel, wherein the main channel comprises an inner wall and an outer wall with a first void space between the inner wall and the outer wall, wherein the inner wall and the outer wall are composed of a polymer; and (b) an extracellular matrix material infused with living cells disposed in the first void space, and wherein the first void space comprises a microstructure comprising a plurality of microchannels.

[0089] Embodiment 2. The vascular graft of embodiment 1, wherein the main channel branches into two secondary channels at the second opening.

[0090] Embodiment 3. The vascular graft of embodiment 1 or 2, wherein the polymer is biodegradable.

[0091] Embodiment 4. The vascular graft of any of embodiments 1-3, wherein the polymer is biocompatible.

[0092] Embodiment 5. The vascular graft of any one of embodiments 1-4, wherein the polymer is a polyester.

[0093] Embodiment 6. The vascular graft of any one of embodiments 1-4, wherein the polymer is polycaprolactone.

[0094] Embodiment 7. The vascular graft of any one of embodiments 1-6, wherein the cells infused into the extracellular matrix material of living cells are stem cells.

[0095] Embodiment 8. The vascular graft of any one of embodiments 1-7, wherein the extracellular matrix material comprises a basement membrane matrix.

[0096] Embodiment 9. The vascular graft of any one of embodiments 1-8, wherein the plurality of microchannels within the microstructure of the first void space are arranged to form a regular pattern.

[0097] Embodiment 10. The vascular graft of embodiment 9, wherein the pattern is hexagonal.

[0098] Embodiment 11. The vascular graft of any of embodiments 1-10, wherein the plurality of microchannels contain cells.

[0099] Embodiment 12. The vascular graft of any one of embodiments 1-11, wherein the lumen diameter of the main channel is from about 1 cm to about 10 cm.

[0100] Embodiment 13. The vascular graft of any of Embodiments 1-12, wherein the thickness of the first void space is from about 1 mm to about 2 cm.

[0101] Embodiment 14. The vascular graft of any of embodiments 1-13, wherein one of the microchannels from the plurality of microchannels has a diameter of about 1 μm to about 500 μm.

[0102] Embodiment 15. The vascular graft of any of embodiments 1-14, wherein the hollow cylinder comprises a first end and a second end, and the first opening is at the first end and the second opening is at the second end, wherein the first opening and the second opening form a straight passage through the hollow cylinder.

[0103] Embodiment 16. The vascular graft of any one of embodiments 1-15, wherein the main channel further comprises a third channel connected to the main channel, wherein the third channel comprises a distal end and a proximal end, wherein the proximal end is connected to the main channel.

[0104] Embodiment 17. The vascular graft of embodiment 16, wherein the distal end of the third channel comprises a spheroid of cells.

[0105] Embodiment 18. The vascular graft of embodiment 16 or 17, wherein the third channel is a hollow cylinder comprising an inner wall and an outer wall to form a second void space, wherein the inner wall and the outer wall are composed of a polymer.

[0106] Embodiment 19. The vascular graft of embodiment 18, wherein an extracellular matrix material infused with living cells is disposed within the second void space.

[0107] Embodiment 20. A vascular graft comprising a hollow cylinder, wherein the hollow cylinder comprises a first opening and a second opening, and wherein the hollow cylinder comprises: (a) a main channel, wherein the main channel comprises an inner wall and an outer wall with a void space between the inner wall and the outer wall, wherein the inner wall and the outer wall are composed of a polymer; and (b) an extracellular matrix material infused with living cells disposed within the void space, and wherein the void space comprises a microstructure comprising a plurality of microchannels, wherein the vascular graft is immersed in a medium that promotes growth of cells in the extracellular matrix material infused with living cells.

[0108] Embodiment 21. A method for increasing the flow of a biological fluid in a blood vessel of a subject in need thereof, the method comprising implanting a vascular graft in the subject, wherein the vascular graft comprises a hollow cylinder, and wherein the hollow cylinder comprises: (a) a main channel, wherein the main channel comprises an inner wall and an outer wall with a void space between the inner wall and the outer wall, wherein the inner wall and the outer wall are composed of a polymer; and (b) an extracellular matrix material infused with living cells disposed in the void space, and wherein the void space comprises a microstructure comprising a plurality of microchannels, wherein implanting the vascular graft in the subject increases the flow of a biological fluid in the subject's blood vessel.

[0109] Embodiment 22. The method of embodiment 21, wherein the subject suffers from cardiovascular disease.

[0110] Embodiment 23. The method of embodiment 21 or 22, wherein the biological fluid is blood.

[0111] Embodiment 24. The method of any one of Embodiments 21-23, wherein the blood vessel is an artery.

[0112] Embodiment 25. A method for printing a vascular graft, the method comprising: (a) depositing a polymer on a substrate to form an inner wall; (b) depositing an extracellular matrix material infused with living cells on the inner wall; (c) depositing a polymer on the extracellular matrix material infused with living cells to form an outer wall, wherein the deposition of steps (a), (b), and (c) forms a hollow cylinder, wherein the hollow cylinder comprises a first opening and a second opening, and wherein the hollow cylinder comprises a main channel, wherein the main channel comprises an inner wall and an outer wall; and wherein the vascular graft is printed to provide a microstructure comprising a plurality of microchannels in the void space.

[0113] Embodiment 26. The method of embodiment 25, further comprising immersing the substrate in a medium that promotes cell growth in the extracellular matrix material infused with living cells.

[0114] Embodiment 27. The method of Embodiment 25 or 26, wherein the main channel comprises a fugitive ink.

Claims

1. A vascular graft comprising a hollow cylinder, wherein the hollow cylinder comprises: First opening; a second opening; and a main channel, wherein the main channel comprises an inner wall and an outer wall with a first void space between the inner wall and the outer wall, wherein the inner wall and the outer wall are composed of a polymer; The first void space comprises a microstructure, wherein the microstructure comprises a hollow tube, wherein the hollow tube comprises (i) a tube wall having a plurality of microchannels and (ii) an extracellular matrix material infused with living cells disposed within the hollow space of the hollow tube.

2. The vascular graft according to claim 1, wherein the main channel branches into two secondary channels at the second opening.

3. The vascular graft of claim 1, wherein the polymer is biodegradable.

4. The vascular graft of claim 1, wherein the polymer is biocompatible.

5. The vascular graft of claim 1, wherein the polymer is polyester.

6. The vascular graft of claim 1, wherein the polymer is polycaprolactone.

7. The vascular graft according to claim 1, wherein the cells in the living cell-infused extracellular matrix material are stem cells.

8. The vascular graft of claim 1, wherein the extracellular matrix material comprises basement membrane matrix.

9. The vascular graft of claim 1, wherein the plurality of microchannels within the microstructure of the first void space are arranged to form a regular pattern.

10. The vascular graft of claim 9, wherein the pattern is hexagonal.

11. The vascular graft of claim 1, wherein the plurality of microchannels contain cells.

12. The vascular graft of claim 1, wherein the lumen diameter of the main channel is 1 cm to 10 cm.

13. The vascular graft of claim 1, wherein the first void space has a thickness of 1 mm to 2 cm.

14. The vascular graft of claim 1, wherein one of the microchannels from the plurality of microchannels has a diameter of 1 μm to 500 μm.

15. The vascular graft of claim 1, wherein the hollow cylinder comprises a first end and a second end, and the first opening is at the first end and the second opening is at the second end, wherein the first opening and the second opening form a straight passage through the hollow cylinder.

16. The vascular graft of claim 1, wherein the main channel further comprises a third channel connected to the main channel, wherein the third channel comprises a distal end and a proximal end, wherein the proximal end is connected to the main channel.

17. The vascular graft of claim 16, wherein the distal end of the third channel comprises a spheroid of cells.

18. The vascular graft of claim 16, wherein the third channel is a hollow cylinder comprising an inner wall and an outer wall to form a second void space, wherein the inner wall and the outer wall are composed of a polymer.

19. The vascular graft of claim 18, wherein an extracellular matrix material infused with living cells is disposed within the second void space.

20. The vascular graft according to claim 1, The vascular graft is immersed in a medium that promotes cell growth in the extracellular matrix material infused with living cells.

21. A method of printing a vascular graft, the method comprising: a) depositing a polymer on a substrate to form an inner wall; b) depositing an extracellular matrix material injected with living cells on the inner wall; c) depositing the polymer on the extracellular matrix material injected into the living cells to form an outer wall, wherein the depositing of step (a), step (b) and step (c) forms a hollow cylinder, wherein the hollow cylinder comprises a first opening, a second opening and a main channel, wherein the main channel comprises the inner wall and the outer wall; and wherein the vascular graft is printed to provide a first void space between the inner wall and the outer wall, wherein the first void space comprises a microstructure, wherein the microstructure comprises a hollow tube, wherein the hollow tube comprises a tube wall comprising a plurality of microchannels.

22. The method according to claim 21, further comprising: d) immersing the substrate in a medium that promotes cell growth in the extracellular matrix material infused with living cells.

23. The method of claim 21, wherein the primary channel contains fugitive ink.